// company-profile
Akebia Therapeutics, Inc.
AKBA// activity-summary
Recent insider activity is bullish. Over the last 30 days, 12 insiders purchased shares. Buying was led by FRIESON RON.
// 90-day insight
Over the last 90 days, Akebia Therapeutics, Inc. insiders bought $0 across 13 transactions with no open-market sales.
- Most active insider: FRIESON RON with 2 transactions totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Akebia Therapeutics, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | FRIESON RON | AKBA | Award | 35,700 | $0.00 | $0K |
| Jun 17, 2026 | Smith Cynthia | AKBA | Award | 35,700 | $0.00 | $0K |
| Jun 17, 2026 | ROGERS MICHAEL W | AKBA | Award | 35,700 | $0.00 | $0K |
| Jun 17, 2026 | Wolf Myles | AKBA | Award | 53,600 | $0.00 | $0K |
| Jun 17, 2026 | ZUMWALT LEANNE M | AKBA | Award | 53,600 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.